Literature DB >> 25352018

Long-term prevalence and predictors of urinary incontinence among women in the Diabetes Prevention Program Outcomes Study.

Suzanne Phelan1, Alka M Kanaya, Yong Ma, Eric Vittinghoff, Elizabeth Barrett-Connor, Rena Wing, John W Kusek, Trevor J Orchard, Jill P Crandall, Maria G Montez, Jeanette S Brown.   

Abstract

OBJECTIVES: To examine the long-term prevalence and predictors of weekly urinary incontinence in the Diabetes Prevention Program Outcomes Study, a follow-up study of the Diabetes Prevention Program randomized clinical trial of overweight adults with impaired glucose tolerance.
METHODS: This analysis included 1778 female participants of the Diabetes Prevention Program Outcomes Study who had been randomly assigned during the Diabetes Prevention Program to intensive lifestyle intervention (n = 582), metformin (n = 589) or placebo (n = 607). The study participants completed semi-annual assessments after the final Diabetes Prevention Program visit and for 6 years until October 2008.
RESULTS: At the study entry, the prevalence of weekly urinary incontinence was lower in the intensive lifestyle intervention group compared with the metformin and placebo groups (44.2% vs 51.8%, 48.0% urinary incontinence/week, P = 0.04); during the 6-year follow-up period, these lower rates in intensive lifestyle intervention were maintained (46.7%, 53.1%, 49.9% urinary incontinence/week; P = 0.03). Statistically adjusting for urinary incontinence prevalence at the end of the Diabetes Prevention Program, the treatment arm no longer had a significant impact on urinary incontinence during the Diabetes Prevention Program Outcomes Study. Independent predictors of lower urinary incontinence during the Diabetes Prevention Program Outcomes Study included lower body mass index (odds ratio 0.988, 95% confidence interval 0.982-0.994) and greater physical activity (odds ratio 0.999, 95% confidence interval 0.998-1.000) at the Diabetes Prevention Program Outcomes Study entry, and greater reductions in body mass index (odds ratio 0.75, 95% confidence interval 0.60-0.94) and waist circumference (odds ratio 0.998, 95% confidence interval 0.996-1.0) during the Diabetes Prevention Program Outcomes Study. Diabetes was not significantly related to urinary incontinence.
CONCLUSIONS: Intensive lifestyle intervention has a modest positive and enduring impact on urinary incontinence, and should be considered for the long-term prevention and treatment of urinary incontinence in overweight/obese women with glucose intolerance.
© 2014 The Japanese Urological Association.

Entities:  

Keywords:  Diabetes Prevention Program Outcomes Study; lifestyle intervention; urinary incontinence; weight loss

Mesh:

Substances:

Year:  2014        PMID: 25352018      PMCID: PMC4387889          DOI: 10.1111/iju.12654

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  32 in total

1.  A population study of urinary incontinence and nocturia among women aged 20-59 years. Prevalence, well-being and wish for treatment.

Authors:  E Samuelsson; A Victor; G Tibblin
Journal:  Acta Obstet Gynecol Scand       Date:  1997-01       Impact factor: 3.636

Review 2.  Advanced maternal age as a risk factor for stress urinary incontinence: a review of the literature.

Authors:  Adonis Hijaz; Zhina Sadeghi; Lauren Byrne; Jack Cheng-Tsung Hou; Firouz Daneshgari
Journal:  Int Urogynecol J       Date:  2011-09-08       Impact factor: 2.894

3.  Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial.

Authors:  Suzanne Phelan; Alka M Kanaya; Leslee L Subak; Patricia E Hogan; Mark A Espeland; Rena R Wing; Kathryn L Burgio; Vicki DiLillo; Amy A Gorin; Delia S West; Jeanette S Brown
Journal:  J Urol       Date:  2012-01-20       Impact factor: 7.450

4.  Two-year incidence, remission, and change patterns of urinary incontinence in noninstitutionalized older adults.

Authors:  A R Herzog; A C Diokno; M B Brown; D P Normolle; B M Brock
Journal:  J Gerontol       Date:  1990-03

5.  The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  1999-04       Impact factor: 19.112

6.  Urinary incontinence and diabetes in postmenopausal women.

Authors:  Sara L Jackson; Delia Scholes; Edward J Boyko; Linn Abraham; Stephan D Fihn
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

7.  Weight loss to treat urinary incontinence in overweight and obese women.

Authors:  Leslee L Subak; Rena Wing; Delia Smith West; Frank Franklin; Eric Vittinghoff; Jennifer M Creasman; Holly E Richter; Deborah Myers; Kathryn L Burgio; Amy A Gorin; Judith Macer; John W Kusek; Deborah Grady
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

8.  Diagnostic classification of female urinary incontinence: an epidemiological survey corrected for validity.

Authors:  H Sandvik; S Hunskaar; A Vanvik; H Bratt; A Seim; R Hermstad
Journal:  J Clin Epidemiol       Date:  1995-03       Impact factor: 6.437

9.  Urological complications of obesity and diabetes.

Authors:  Firouz Daneshgari; Jeanette S Brown; John W Kusek; Leroy M Nyberg
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

10.  Cystometric parameters and the activity of signaling proteins in association with the compensation or decompensation of bladder function in an animal experimental model of partial bladder outlet obstruction.

Authors:  Bo-Hwa Choi; Long-Hu Jin; Khae-Hawn Kim; Sung-An Kang; Ju-Hee Kang; Sang-Min Yoon; Chang-Shin Park; Tack Lee
Journal:  Int J Mol Med       Date:  2013-09-30       Impact factor: 4.101

View more
  6 in total

Review 1.  Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.

Authors:  Linda Vignozzi; Mauro Gacci; Mario Maggi
Journal:  Nat Rev Urol       Date:  2016-01-12       Impact factor: 14.432

Review 2.  Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; Gabriel Gimenez-Perez; Didac Mauricio; Marta Roqué I Figuls; Maria-Inti Metzendorf; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2017-12-04

3.  Remission and Transition of Female Urinary Incontinence and Its Subtypes and the Impact of Body Mass Index on This Progression: A Nationwide Population-Based 4-Year Longitudinal Study in China.

Authors:  Haiyu Pang; Tao Xu; Zhaoai Li; Jian Gong; Qing Liu; Yuling Wang; Juntao Wang; Zhijun Xia; Lan Zhu
Journal:  J Urol       Date:  2022-04-15       Impact factor: 7.600

4.  DiabetesSistersVoices: Virtual Patient Community to Identify Research Priorities for Women Living With Diabetes.

Authors:  Peijin Han; Wanda Nicholson; Anna Norton; Karen Graffeo; Richard Singerman; Steven King; Aditi Sundaresan; Wendy Bennett
Journal:  J Med Internet Res       Date:  2019-05-10       Impact factor: 5.428

5.  Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.

Authors:  Kasper S Madsen; Yuan Chi; Maria-Inti Metzendorf; Bernd Richter; Bianca Hemmingsen
Journal:  Cochrane Database Syst Rev       Date:  2019-12-03

6.  Burden of Urological Complications in Men and Women With Long-standing Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort.

Authors:  Hunter Wessells; Barbara H Braffett; Sarah K Holt; Alan M Jacobson; John W Kusek; Catherine Cowie; Rodney L Dunn; Aruna V Sarma
Journal:  Diabetes Care       Date:  2018-08-13       Impact factor: 19.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.